⇄

1 Article(s) Download
	PMID	Title	Pub. Year	#Total Relationships
1	26912052	Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells.	2016 Feb 24	1